How much funding has InjectSense raised?

InjectSense has disclosed $13.9M raised across 2 rounds.

Where is InjectSense headquartered?

InjectSense is headquartered in Emeryville, US.

InjectSense

Emeryville, US · Founded 2014 · Delaware corporation

Injectsense develops implant-based digital health systems that use semiconductor technology to provide medical staff with continuous long-term monitoring data for therapy management, with an ophthalmology focus including eye-pressure markers. The company combines ultra-low power IC design, telemetry, and miniaturization with medical device and software expertise.

Digital Health Hardware Medical Devices Semiconductors

Founders & leadership

Enrique MalaretNamed on SEC filing

Ariel CaoinNamed on SEC filing

Zack ScottNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$13.9M disclosed across 2 rounds · 2017–2019

▶$4.1MraisedApr 2019 · 23 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Enrique MalaretExecutive Officer, Director
Ariel CaoExecutive Officer, Director
Zack ScottDirector

Offering amount: $8.4M
Amount sold: $4.1M
First sale: Apr 2019
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$9.8MraisedOct 2017 · 42 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Enrique MalaretExecutive Officer, Director
Ariel CaoExecutive Officer, Director

Offering amount: $9.8M
Amount sold: $9.8M
First sale: Oct 2017
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 6

by search overlap

Infusense7 shared keywordsInfuSense develops an electrochemical sensing technology platform that detects analytes at sub-therapeutic levels, delivering sample analysis results within minutes. The portable device is designed to bring laboratory-scale testing capabilities into a handheld form factor.

Senseonics Holdings7 shared keywords

CranioSense6 shared keywordsCranioSense develops IPASS, a non-invasive medical device that measures intracranial pressure using a forehead patch and handheld device, eliminating the need for invasive skull drilling in traumatic brain injury assessment.

Clearsense6 shared keywordsClearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views. The company targets health systems to reduce costs, improve operational efficiency, accelerate research and impact care outcomes.

Nirsense4 shared keywordsNIRSense builds ruggedized, wireless hospital-quality patient monitors that measure tissue oxygen kinetics and other physiological data, including arterial (SpO2) and tissue (StO2) oxygenation, to help clinicians diagnose and treat critical conditions such as cardiogenic shock. Its devices are designed for use in uncontrolled environments including emergency and intensive care settings and military front lines.

Sisense4 shared keywordsSisense provides embedded analytics software that enables teams to integrate data visualization and insights into business applications. The platform serves product development teams and enterprises seeking to build data-driven features into their software products.

Companies competing with InjectSense for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2022	$1.6M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does InjectSense do?: Injectsense develops implant-based digital health systems that use semiconductor technology to provide medical staff with continuous long-term monitoring data for therapy management, with an ophthalmology focus including eye-pressure markers. The company combines ultra-low power IC design, telemetry, and miniaturization with medical device and software expertise.
How much funding has InjectSense raised?: InjectSense has disclosed $13.9M raised across 2 rounds.
Where is InjectSense headquartered?: InjectSense is headquartered in Emeryville, US.